Security key
09073Q105
- Security type / class
- Equity / ADSs
- Total 13F shares
- 209,677
- Total 13F value
- $153,000
- Share change
- -124,148
- SEC-reported price per share
- $0.73
- Number of holders
- 10
- Value change
- -$107,274
- Number of buys
- 3
- Number of sells
- 7
- Shares outstanding
- 592,878
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
10
Top holders
10
BVXV full security history
Ownership snapshot
Full 13F holder table
Scinai Immunotherapeutics Ltd. SEC filings
Scinai Immunotherapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ENVESTNET ASSET MANAGEMEN...
Disclosed value leader
ENVESTNET ASSET MANAGEMEN...
Comparable rows
13/13
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 28%
Showing 1-6 of 13 holder rows.
Quick read
ENVESTNET ASSET MANAGEMENT INC leads the comparable SEC ownership view at 28%.
13 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ENVESTNET ASSET MANAGEMENT INC's linked filing trail.
Comparable ownership
Top 5
ENVESTNET ASSET MANAGEMENT INC
28%
TRUE Private Wealth Advisors
9.4%
MORGAN STANLEY
5.6%
CITADEL ADVISORS LLC
4%
RENAISSANCE TECHNOLOGIES LLC
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
28%
|
$191,000
163,423 shares
|
— | 30 Jun 2022 |
| TRUE Private Wealth Advisors |
13F
Company
|
9.4%
|
$64,000
55,500 shares
|
— | 30 Jun 2022 |
| MORGAN STANLEY |
13F
Company
|
5.6%
|
$39,000
33,281 shares
|
— | 30 Jun 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
4%
|
$28,000
23,844 shares
|
— | 30 Jun 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
3.1%
|
$21,000
18,300 shares
|
— | 30 Jun 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.3%
|
$16,000
13,768 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
209,677
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
13
Q3 2022 holders
10
Holder diff
-3
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|